Latest News From Lumira Ventures

Cardiac Dimensions® Inc. Announces Closing of $35.5 Million Round of Financing. JJDC & Lumira Capital Co-Lead Round, Providing Funds to Be Used to Support FDA Clinical Trials of the CARILLON™ Mitral Contour System™

admin Cardiac Dimensions, Portfolio News

KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Dimensions®, Inc. announced today it has closed $35.5 million in new venture capital. This Series D financing was co-led by Johnson & Johnson Development Corp. (JJDC) and Lumira Capital, and included Mitsubishi UFJ Capital, West River Capital, …

Immunicon Corporation Announces Independent Studies to Be Presented at 2007 San Antonio Breast Cancer Symposium That Confirm Utility of the CellSearch™ Circulating Tumor Cell Kit

admin Portfolio News

HUNTINGDON VALLEY, Pa. & SAN ANTONIO–(BUSINESS WIRE)–Immunicon Corporation (NASDAQ-CM:IMMC) announced today that three independent studies featuring Immunicon’s CellTracks® technology and the CellSearch™ Circulating Tumor Cell Kit will be presented at the 30th Annual San Antonio Breast Cancer Symposium (SABCS). The …

Replidyne Provides Strategic Update

admin Portfolio News

LOUISVILLE, Colo., Dec. 10 /PRNewswire-FirstCall/ — Replidyne, Inc. today announced an operational restructuring to align critical resources with strategic priorities. These priorities include identifying a partner for Replidyne’s late-stage antibiotic, faropenem medoxomil (faropenem), advancing and expanding its infectious disease pipeline, …